Editas Medicine (EDIT) Invested Capital (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Invested Capital data on file, last reported at $85.9 million in Q4 2025.

• Quarterly Invested Capital fell 55.2% year-over-year to $85.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $85.9 million (down 55.2% YoY) and the FY2025 annual result came in at $85.9 million, down 55.2% from the prior year.
• Invested Capital grew to $85.9 million in Q4 2025 per EDIT's latest filing, from $72.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $638.0 million in Q1 2021 and bottomed at $72.5 million in Q3 2025.
• The 5-year median for Invested Capital is $354.8 million (2023), against an average of $340.9 million.
• The widest annual swing landed in 2021, when Invested Capital surged 171.99%; it then slumped 67.3% in 2025.
• Tracing EDIT's Invested Capital over 5 years: stood at $553.6 million in 2021, then plunged by 34.85% to $360.7 million in 2022, then slipped by 3.21% to $349.1 million in 2023, then plunged by 45.08% to $191.7 million in 2024, then slumped by 55.2% to $85.9 million in 2025.
• Per Business Quant, the three latest EDIT Invested Capital figures stand at $85.9 million (Q4 2025), $72.5 million (Q3 2025), and $75.9 million (Q2 2025).

Peer Comparison